FDA MedWatch

Marlex Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Digoxin Tablets USP, 0.125mg and Digoxin Tablets USP, 0.25mg Due to Label Mix-Up

New Castle, Delaware, Marlex Pharmaceuticals, Inc. is voluntarily recalling one lot of Digoxin Tablets USP, 0.125mg and one lot of Digoxin Tablets USP, 0.25mg to the consumer level due to Label Mix-Up. Bottles of Digoxin Tablets, USP 0.125mg s are incorrectly labeled and contain Digoxin Tablets USP,

Inmar Supply Chain Solutions, LLC, Issues a Voluntary Recall of Product Stored at its Arlington, Texas Facility Due to Conditions at the Facility

Inmar Supply Chain Solutions, LLC (“Inmar”), is voluntarily recalling FDA regulated products* contained in pallets stored in Inmar’s Arlington, Texas facility between May 1, 2022, and June 30, 2023, the (“FDA Recalled Products”). The FDA Recalled Products were stored in this facility during a time

Dräger Issues Worldwide Voluntary Recall Notification for Carina Sub-Acute Care Ventilators to Address Possible Contamination of the Breathing Gas with 1,3-Dichloropropan-2-ol

Drägerwerk AG & Co. KGaA initiated a voluntary recall notification for Dräger Carina Sub-Acute Care Ventilators to address possible contamination of the breathing gas with 1,3-Dichloropropan-2-ol, a constituent of the PE-PUR foam used for sound insulation. To date, Dräger’s market surveillance act